The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas
Jane L. Anderson(Cincinnati Children's Hospital Medical Center), Biplab Dasgupta(Emory University), Mariko DeWire(Cincinnati Children's Hospital Medical Center), Amanda Klotter(Cincinnati Children's Hospital Medical Center), Matthew Weirauch(Cincinnati Children's Hospital Medical Center), Ronald R. Waclaw(University of Cincinnati Medical Center), Eric H. Raabe(Johns Hopkins University), Rachid Drissi(Nationwide Children's Hospital), Jianqiang Wu(Cincinnati Children's Hospital Medical Center), Maryam Fouladi(Nationwide Children's Hospital), Lili Miles(St Nicholas Hospital), Nicole Oatman(Cincinnati Children's Hospital Medical Center), Lindsey M. Hoffman(St Nicholas Hospital), Ranjithmenon Muraleedharan(Cincinnati Children's Hospital Medical Center), Satarupa Sengupta(Cincinnati Children's Hospital Medical Center), Lionel M.L. Chow(Wright State University)
Cited by 38
Related Papers
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
|Journal of Clinical Oncology|2018|433
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
|Science Translational Medicine|2017|427